https://www.nature.com/articles/s41598-022-21315-z
0
0
Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy | Scientific Reports - Nature.com
10/7/22 at 9:15am
Organization
Nature.com
Authors
Details
54 words
Summarize
Health Infectious Diseases Serum IL-1β hepatitis B virus reactivation Scientific Reports - Nature.com Scientific Reports - Serum IL-1β
Scientific Reports - Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy
Create an account or login to join the discussion